HSP90AA1 and posterior cortical atrophy: These analyses led to the selection of a series of compounds, which were experimentally tested in vitro for their inhibition ability against Hsp90 and HDAC6, and for their antiproliferative activity in PC-3 and LNCaP PCA cell lines.